Monte S. Willis
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
480
Citations
12,767
Est. group size
—
Recurring co-author estimate
Active years
33
Publishing since 1994
Monte S. Willis studies how heart and muscle tissues maintain healthy protein levels and how failures in these processes contribute to heart disease. A major focus is the ubiquitin-proteasome system and specific enzymes (such as MuRF1) that tag and break down proteins, along with how these pathways affect cardiac hypertrophy, heart failure, and muscle wasting. The work also extends to metabolomics-based studies of how cancer drugs affect the heart and other organs.
Publication output has generally declined over the last decade, with a notable peak in 2020 followed by lower activity averaging under three papers per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non‐targeted metabolomics analysis
UNC Libraries · 2025
- Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo
UNC Libraries · 2025
- Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension
Journal of the American Society of Nephrology · 2024
- Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Myocarditis or Myositis? Rising, Declining, and Rising of Critical Cardiac Troponin T Levels in a Patient Post Immune Checkpoint Inhibitor Therapy
The Journal of Applied Laboratory Medicine · 2024
- The Head and the Heart The Alzheimer’s Connection∗
UNC Libraries · 2024
- Pathophysiology of heart failure and an overview of therapies
Cardiovascular Pathology · 2022
- The Role of Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Bone Microarchitecture In Vivo
Cell Biochemistry and Biophysics · 2022
- Correction: The Role of Bone Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Microarchitecture In Vivo
Cell Biochemistry and Biophysics · 2022
- Muscle RING finger-1 is required to prevent age-related cardiac hypertrophy and interstitial remodelling
Vascular Pharmacology · 2022
- Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover
Nature Communications · 2021
- Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
Current Pathobiology Reports · 2021
- Inhibitory kappa B kinase-β is a target for specific nuclear factor kappa B-mediated delayed cardioprotection
UNC Libraries · 2021
- The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal Muscle
UNC Libraries · 2021
- The ubiquitin–proteasome system in cardiac dysfunction
UNC Libraries · 2021
- UNC Libraries×72
- The FASEB Journal×19
- Figshare×9
- bioRxiv (Cold Spring Harbor Laboratory)×6
- American Journal Of Pathology×5
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile